Salesforce (CRM), Moderna Partner to Unify Global Operations via Agentforce Life Sciences

Salesforce Inc. (NYSE:CRM) is one of the cheap stocks to buy for the next 10 years. On April 28, Salesforce and Moderna announced a new partnership to unify the biotech company’s global commercial operations through Agentforce Life Sciences. This collaboration aims to create a single, connected platform that integrates data from sources like SAP and e-commerce to provide a 360-degree view of healthcare provider interactions. The initiative is designed to streamline field services and customer engagement across multiple regions.

The platform uses AI and automation to deliver “next best actions” and automated cycle planning, empowering Moderna’s global teams with real-time insights. By consolidating regional systems and incorporating IQVIA OneKey reference data, the system ensures a secure and trusted source of truth for commercial activities. This allows for more personalized, data-driven marketing campaigns and improved customer service at scale.

Salesforce (CRM), Moderna Partner to Unify Global Operations via Agentforce Life Sciences

Built on an open ecosystem, the architecture connects medical, commercial, and patient service operations without vendor lock-in. This unified approach supports Moderna’s rapid global expansion and helps modernize its infrastructure. Ultimately, the partnership focuses on using intelligent recommendations and a cohesive digital foundation to drive meaningful engagement and operational excellence in the life sciences sector.

Salesforce Inc. (NYSE:CRM) is a global enterprise software company that provides CRM and cloud-based business applications across sales, service, marketing, commerce, and data analytics. Its Customer 360 platform, powered by data tools and trusted AI, enables organizations to unify customer data and drive personalized engagement.

While we acknowledge the risk and potential of CRM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CRM and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.